Fidelity Investments’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $114M | Sell |
1,398,261
-130,101
| -9% | -$9.39M | 0.01% | 1189 |
|
|
2026
Q1 | $104M | Sell |
1,528,362
-152,854
| -9% | -$10.8M | 0.01% | 1159 |
|
|
2025
Q4 | $128M | Buy |
1,681,216
+69,441
| +4% | +$5.05M | 0.01% | 1064 |
|
|
2025
Q3 | $98.9M | Sell |
1,611,775
-106,512
| -6% | -$5.55M | 0.01% | 1186 |
|
|
2025
Q2 | $83.9M | Sell |
1,718,287
-295,275
| -15% | -$14M | ﹤0.01% | 1192 |
|
|
2025
Q1 | $103M | Buy |
2,013,562
+1,193,518
| +146% | +$59.6M | 0.01% | 1085 |
|
|
2024
Q4 | $37M | Sell |
820,044
-237,138
| -22% | -$10.1M | ﹤0.01% | 1503 |
|
|
2024
Q3 | $39.2M | Sell |
1,057,182
-46,917
| -4% | -$1.57M | ﹤0.01% | 1472 |
|
|
2024
Q2 | $33.8M | Sell |
1,104,099
-622,963
| -36% | -$20.2M | ﹤0.01% | 1466 |
|
|
2024
Q1 | $50.2M | Sell |
1,727,062
-87,359
| -5% | -$2.45M | ﹤0.01% | 1330 |
|
|
2023
Q4 | $50M | Sell |
1,814,421
-6,650,963
| -79% | -$152M | ﹤0.01% | 1291 |
|
|
2023
Q3 | $190M | Sell |
8,465,384
-1,787,740
| -17% | -$66.5M | 0.02% | 721 |
|
|
2023
Q2 | $417M | Buy |
10,253,124
+669,956
| +7% | +$32.8M | 0.04% | 467 |
|
|
2023
Q1 | $464M | Sell |
9,583,168
-1,199,138
| -11% | -$54.8M | 0.04% | 435 |
|
|
2022
Q4 | $412M | Buy |
10,782,306
+51,162
| +0.5% | +$2.13M | 0.04% | 460 |
|
|
2022
Q3 | $539M | Buy |
10,731,144
+30,307
| +0.3% | +$1.48M | 0.06% | 331 |
|
|
2022
Q2 | $429M | Sell |
10,700,837
-26,308
| -0.2% | -$922K | 0.04% | 420 |
|
|
2022
Q1 | $400M | Buy |
10,727,145
+122,460
| +1% | +$4.72M | 0.03% | 514 |
|
|
2021
Q4 | $422M | Buy |
10,604,685
+13,954
| +0.1% | +$534K | 0.03% | 518 |
|
|
2021
Q3 | $394M | Buy |
10,590,731
+22,345
| +0.2% | +$918K | 0.03% | 520 |
|
|
2021
Q2 | $447M | Buy |
10,568,386
+20,038
| +0.2% | +$859K | 0.04% | 476 |
|
|
2021
Q1 | $499M | Buy |
10,548,348
+334,493
| +3% | +$19.9M | 0.04% | 434 |
|
|
2020
Q4 | $623M | Buy |
10,213,855
+79,879
| +0.8% | +$4.71M | 0.06% | 336 |
|
|
2020
Q3 | $474M | Buy |
10,133,976
+3,439,232
| +51% | +$169M | 0.05% | 351 |
|
|
2020
Q2 | $340M | Buy |
6,694,744
+1,816,519
| +37% | +$89.3M | 0.04% | 421 |
|
|
2020
Q1 | $218M | Buy |
4,878,225
+2,455,383
| +101% | +$124M | 0.03% | 480 |
|
|
2019
Q4 | $116M | Sell |
2,422,842
-29,740
| -1% | -$1.26M | 0.01% | 860 |
|
|
2019
Q3 | $82.9M | Buy |
2,452,582
+78,140
| +3% | +$3.4M | 0.01% | 967 |
|
|
2019
Q2 | $107M | Sell |
2,374,442
-62,293
| -3% | -$2.46M | 0.01% | 883 |
|
|
2019
Q1 | $91.7M | Sell |
2,436,735
-365,782
| -13% | -$12.3M | 0.01% | 946 |
|
|
2018
Q4 | $96.2M | Buy |
2,802,517
+36,729
| +1% | +$1.32M | 0.01% | 862 |
|
|
2018
Q3 | $130M | Buy |
2,765,788
+1,462,534
| +112% | +$60.5M | 0.01% | 831 |
|
|
2018
Q2 | $44M | Buy |
1,303,254
+187,900
| +17% | +$5.86M | 0.01% | 1339 |
|
|
2018
Q1 | $30.2M | Sell |
1,115,354
-42,800
| -4% | -$1.08M | ﹤0.01% | 1528 |
|
|
2017
Q4 | $19.3M | Hold |
1,158,154
| – | – | ﹤0.01% | 1738 |
|
|
2017
Q3 | $23.2M | Buy |
1,158,154
+454,181
| +65% | +$8.89M | ﹤0.01% | 1645 |
|
|
2017
Q2 | $12.9M | Buy |
703,973
+27,500
| +4% | +$371K | ﹤0.01% | 1850 |
|
|
2017
Q1 | $6.66M | Sell |
676,473
-55,571
| -8% | -$673K | ﹤0.01% | 2100 |
|
|
2016
Q4 | $7.99M | Buy |
732,044
+481,556
| +192% | +$5.05M | ﹤0.01% | 2043 |
|
|
2016
Q3 | $3.51M | Sell |
250,488
-885,723
| -78% | -$7.2M | ﹤0.01% | 2260 |
|
|
2016
Q2 | $7.98M | Sell |
1,136,211
-225
| -0% | -$1.65K | ﹤0.01% | 2056 |
|
|
2016
Q1 | $7.32M | Sell |
1,136,436
-793,591
| -41% | -$13.8M | ﹤0.01% | 2053 |
|
|
2015
Q4 | $62.5M | Buy |
1,930,027
+482,214
| +33% | +$14.2M | 0.01% | 1175 |
|
|
2015
Q3 | $38.7M | Sell |
1,447,813
-1,225,750
| -46% | -$52.4M | 0.01% | 1359 |
|
|
2015
Q2 | $129M | Sell |
2,673,563
-2,379,773
| -47% | -$139M | 0.02% | 918 |
|
|
2015
Q1 | $307M | Buy |
5,053,336
+12,955
| +0.3% | +$790K | 0.04% | 499 |
|
|
2014
Q4 | $261M | Buy |
5,040,381
+580,004
| +13% | +$25.5M | 0.03% | 557 |
|
|
2014
Q3 | $196M | Sell |
4,460,377
-50,790
| -1% | -$1.59M | 0.03% | 667 |
|
|
2014
Q2 | $118M | Sell |
4,511,167
-348
| -0% | -$7.45K | 0.02% | 916 |
|
|
2014
Q1 | $118M | Buy |
4,511,515
+2,434,297
| +117% | +$65.4M | 0.02% | 891 |
|
|
2013
Q4 | $35.3M | Buy |
2,077,218
+562,200
| +37% | +$9.88M | 0.01% | 1483 |
|
|
2013
Q3 | $32.5M | Buy |
+1,515,018
| New | +$26.3M | 0.01% | 1480 |
|
Other funds holding PTCT
RI
JT
Fidelity Investments's PTCT Position: Q2 2026 in Review
Fidelity Investments reduced its PTC Therapeutics (PTCT) stake by 8.5% in Q2 2026, selling an estimated $9.39M and leaving 1,398,261 shares worth $114M. The position accounts for 0.01% of the portfolio, ranked #1189.
Fidelity Investments first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. The position peaked at $623M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Fidelity Investments held 1,398,261 shares of PTC Therapeutics worth $114M as of Q2 2026.
- Fidelity Investments sold 130,101 PTC Therapeutics shares in Q2 2026, an estimated $9.39M.
- PTC Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1189 holding.
- Fidelity Investments first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
- Fidelity Investments's PTC Therapeutics position peaked at $623M in Q4 2020.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.